Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.6.2571

The Exonuclease 1 Glu589Lys Gene Polymorphism and Cancer Susceptibility: Evidence Based on a Meta-analysis  

Bayram, Suleyman (Adiyaman University, Adiyaman School of Health, Department of Nursing)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.6, 2014 , pp. 2571-2576 More about this Journal
Abstract
Background: Published studies on the association between the exonuclease 1 (EXO1) Glu589Lys polymorphism and cancer susceptibility have yielded conflicting results. Thus, a meta-analysis of published studies was performed to assess the possible association. Materials and Methods: All eligible case-control studies published up to January 2013 on the association between the EXO1 Glu589Lys polymorphism and cancer susceptibility were identified by searching PubMed, Web of Science, Science Direct and hand search. Either fixed-effect or random-effect models were used to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs) using the Comprehensive Meta-Analysis software version 2.2. Results: A total of 4,391 cancer cases and 4,339 controls from 10 studies were included. Overall, no significant association between the EXO1 Glu589Lys polymorphism and cancer susceptibility was observed in either genetic model. However; in subgroup analyses by cancer type, a significant association between EXO1 Glu589Lys and lung cancer risk was found (Lys vs Glu: OR=1.23, 95%CI=1.07-1.41, $p_{heterogeneity}$=0.05). Further, subgroup analysis by ethnicity indicated that there was a statistically increased cancer risk in Asians (Lys vs Glu: OR=1.42, 95%CI=1.30-1.55, $p_{heterogeneity}$=0.07; Lys/Lys vs Glu/Glu: OR=1.93, 95%CI=1.20-3.12, $p_{heterogeneity}$=0.01; Lys/Lys+Glu/Lys vs Glu/Glu: OR=1.52, 95%CI=1.37-1.68, $p_{heterogeneity}$=0.42; Lys/Lys vs Glu/Lys+Glu/Glu: OR=1.68, 95%CI=1.07-2.65, $p_{heterogeneity}$=0.02). However, significant association was absent in Caucasians. Conclusions: This meta-analysis suggests, for the first time, that the EXO1 Glu589Lys polymorphism is not associated with overall cancer susceptibility, although marginal associations were found for lung cancer and Asian subgroups. Additional well-designed studies with larger sample size focusing on different ethnicities and cancer types are needed to confirm these findings.
Keywords
EXO1; polymorphism; EXO1 Glu589Lys polymorphism; cancer susceptibility; meta-analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
2 Ibarrola-Villava M, Pena-Chilet M, Fernandez LP, et al (2011). Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility. Eur J Cancer, 47, 2618-25.   DOI   ScienceOn
3 Jin G, Wang H, Hu Z, et al (2008). Potentially functional polymorphisms of EXO1 and risk of lung cancer in a Chinese population: A case-control analysis. Lung Cancer, 60, 340-6.   DOI   ScienceOn
4 Luo X, Hong XS, Xiong XD, Zeng LQ, Lim CE (2012). A single nucleotide polymorphism in EXO1 gene is associated with cervical cancer susceptibility in Chinese patients. Int J Gynecol Cancer, 22, 220-5.   DOI   ScienceOn
5 Qin Q, Zhang C, Zhu H, et al (2013). Association between survivin -31G>C polymorphism and cancer risk: metaanalysis of 29 studies. J Cancer Res Clin Oncol, [Epub ahead of print].
6 Tsai MH, Tseng HC, Liu CS, et al (2009). Interaction of EXO1 genotypes and smoking habit in oral cancer in Taiwan. Oral Oncol, 45, 90-4.   DOI   ScienceOn
7 Wang HC, Chiu CF, Tsai RY, et al (2009). Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan. Anticancer Res, 29, 3897-901
8 Zienolddiny S, Campa D, Lind H, et al (2006). Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 27, 560-7.   DOI   ScienceOn
9 Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.   DOI   ScienceOn
10 Chang JS, Yeh RF, Wiencke JK, et al (2008). Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Biomarkers Prev, 17, 1368-73.   DOI   ScienceOn
11 DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI   ScienceOn
12 Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
13 Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.   DOI   ScienceOn
14 Bayram S, Akkiz H, Bekar A, et al (2012). The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a casecontrol study. Mol Biol Rep, 39, 5943-51.   DOI   ScienceOn
15 Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.   DOI   ScienceOn
16 Borenstein M, Hedges L, Higgins J, Rothstein H (2007). Comprehensive Meta-analysis Version 2. Biostat, Inc. Englewood, NJ.
17 Hsu NY, Wang HC, Wang CH, et al (2009). Lung cancer susceptibility and genetic polymorphisms of EXO1 gene in Taiwan. Anticancer Res, 29, 725-30.
18 Bau DT, Wang HC, Liu CS, et al (2009). Single-nucleotide polymorphism of the EXO1 gene: association with gastric cancer susceptibility and interaction with smoking in Taiwan. Chin J Physiol, 52, 411-8.   DOI